Applied multiplex allele specific PCR to detect second-line drug resistance among multidrug-resistant tuberculosis in China

Tuberculosis (Edinb). 2017 Dec:107:1-4. doi: 10.1016/j.tube.2017.07.010. Epub 2017 Aug 1.

Abstract

Rapid detection of resistance to the second-line drugs is essential for early initiation of appropriate anti-tubercular treatment regimen among multi-drug tuberculosis (MDR-TB). In this study, we applied a multiplex allele-specific PCR (MAS-PCR) to identify the mutations on codons 90 and 94 of gyrA and nucleotide 1401 of rrs for detecting ofloxacin (OFX) and kanamycin (KAN) resistance in 139 MDR-TB isolates from China. Using the traditional phenotypic method as the reference, MAS-PCR detected resistance to OFX and KAN with sensitivities of 67.3% and 76.5%, respectively, and specificities of 100.0%. Therefore, MAS-PCR assays can be used for rapid detection of second-line drug resistance among MDR-TB in China, enabling early administration of appropriate treatment regimens to the affected MDR-TB patients.

Keywords: Kanamycin; Multidrug-resistant tuberculosis; Multiplex allele specific PCR; Ofloxacin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Bacteriological Techniques*
  • China
  • DNA Gyrase / genetics
  • DNA Mutational Analysis / methods*
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Genotype
  • Humans
  • Kanamycin / therapeutic use
  • Kanamycin Resistance / genetics
  • Microbial Sensitivity Tests
  • Multiplex Polymerase Chain Reaction*
  • Mutation
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics*
  • Mycobacterium tuberculosis / pathogenicity
  • Ofloxacin / therapeutic use
  • Predictive Value of Tests
  • Ribosomal Proteins / genetics
  • Tuberculosis, Multidrug-Resistant / diagnosis
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / microbiology*

Substances

  • Antitubercular Agents
  • Ribosomal Proteins
  • Kanamycin
  • Ofloxacin
  • DNA Gyrase